Riverside, IA, December 18, 2018 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named MedBlox as one of the most innovative Services of 2018.

MedBlox is a decentralized, secure, fully encrypted, and legally compliant means of exchanging electronic health information. The platform enables collaboration between providers, health systems/groups, affiliates, researchers and consumers both locally and globally.

MedBlox enables the free flow of health information by allowing patients, guardians, or health proxies to validate and actively manage their existing electronic health record (EHR), thus alleviating much of a provider’s burden of possession and compliance in the process. Providers will be able to focus on continuity of care, improving quality of life, and empowering patients in active disease prevention.

MedBlox also facilitates continuous health care innovation through a decentralized ledger technology, backed by the industry’s first complete data pipeline. Decentralizing electronic medical data while making it readily available to appropriate institutions worldwide will lead to significant improvements in the medical industry. Having access to this data will help avoid unnecessary medical complications that inherently arise due to incomplete patient medical history.

“We are honored to recognized as an industry leader, and proud to put Iowa on the map as a key innovation center,” says Rice.

MedBlox was selected as part of PM360’s7thAnnual Innovations Issue published each December. This issue was established to serve as a guide to the year’s most innovative Companies, Startups, Divisions, Products, Services, and Strategies from within the healthcare and life sciences industries. This comprehensive overview of the year’s most innovative achievements in these six categories helps other companies in the industry to find potential partners and offerings that can help them advance healthcare and life sciences.

“Our selections represent the companies, offerings, and strategies that demonstrated what we believe to be unique in its ability to impact the industry,” says Anna Stashower, CEO/Publisher of PM360. “We hope others in the industry are able to work with these innovators or use these innovations to better serve patients, physicians, and other healthcare stakeholders.”

PM360 received hundreds of submissions from across the healthcare and life sciences industries. The editorial staff of PM360evaluated each submission and selected their picks for the most innovative, regardless of category. Ultimately, more than 60 total innovations were featured in the issue. Within the Startup category, a total of 8 startups were featured.

All of this year’s selections can be found at:


About Company







About PM360

 PM360is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing the full circle of enriching content, PM360is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.